Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Tufano et al., Front. Cell Dev. Biol., 2021, 9: 718947, doi: 10.3389/fcell.2021.718947 | Link | |
A172 |
Human glioma cells | ATCC CRL-1620 | Human | brain | unknown | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M.C. Burger et al., Int. J. of Oncology, 2012, 41: 235-241, DOI: 10.3892/ijo.2012.1446 | Link | |
A172 |
Human glioma cells | ATCC CRL-1620 | Human | brain | unknown | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
A-2780cis |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Kullmann, 2016, Rheinische Friedrich-Wilhelms-Universität Bonn | Link | ||
A-2780cis |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
|||
A-2780cis |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K4 Transfection System | application note | ![]() |
|||
A-2780cis |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
|||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | C.F.T. Taute, PhD Thesis, 2013, University of the Western Cape | Link | ||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K4 Transfection System | application note | ![]() |
|||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K4 Transfection System | publication | S. Möltgen et al., Cells, 2020, 9, 1322, doi:10.3390/cells9061322 | Link | ||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
|||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
|||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | plasmid | Metafectene PRO | publication | C. P. Masamha et al., Cancer Res., Aug 2009; 69: 6565 - 6572 | Link | |||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. P. Masamha et al., Cancer Res., Aug 2009; 69: 6565 - 6572 | Link | ||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Kullmann, 2016, Rheinische Friedrich-Wilhelms-Universität Bonn | Link | ||
A-2058 |
Human skin melanoma cell line | ATCC CRL-11147 | Human | skin | cell line | adherent | plasmid | Metafectene | publication | E. Cesaro et al., Research Square, 2021, DOI: https://doi.org/10.21203/rs.3.rs-278700/v1 | Link | ||
A-2058 |
Human skin melanoma cell line | ATCC CRL-11147 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | F. Albano et al., Biochimie, 2012, DOI: 10.1016/j.biochi.2012.12.012 | ||
A-2058 |
Human skin melanoma cell line | ATCC CRL-11147 | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | E. Cesaro et al., Research Square, 2021, DOI: https://doi.org/10.21203/rs.3.rs-278700/v1 | Link | |
A-2058 |
Human skin melanoma cell line | ATCC CRL-11147 | Human | skin | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
92.1 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | plasmid | Metafectene PRO | publication | I. Venza et al., Int. Immunopharmacol., 2014, 21: 439–446; doi.org/10.1016/j.intimp.2014.05.024 | ||||
92.1 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Venza et al., Biochem. and Biophys. Res. Commun., 2013, 441: 743–750, doi.org/10.1016/j.bbrc.2013.10.114 | |||
92.1 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Venza et al., Int. Immunopharmacol., 2014, 21: 439–446; doi.org/10.1016/j.intimp.2014.05.024 | |||
8VM |
Human primary glioma cells | Human | nervous system | primary cell | plasmid | Metafectene PRO | application note | ![]() |
|||||
8505C |
Human papillary thyroid cancer cell line | Human | other | cell line | adherent | plasmid | Metafectene PRO | publication | V. Vella et al., Endocrine-Related Cancer, 2019, 197–214, 26: 1, doi.org/10.1530/ERC-18-0310 | Link | |||
786-O |
Human renal adenocarcinoma cell line | ATCC CRL-1932 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | E. Alcaraz, Dissertation, 2015, University of Barcelona |